Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Livzon Pharmaceutical Group ( (HK:1513) ) is now available.
Livzon Pharmaceutical Group has announced the nomination of Ms. Wang Zhiyao as a candidate for the position of independent non-executive director on its board. Ms. Wang has completed the necessary pre-appointment training and obtained the required certification from the Shenzhen Stock Exchange, with her qualifications and independence reviewed and approved without objection. This move is subject to approval at the company’s general meeting, potentially strengthening the board’s expertise and governance.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$37.23 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development and production of various medical products and services.
Average Trading Volume: 1,262,119
Technical Sentiment Signal: Buy
Current Market Cap: HK$34.37B
See more data about 1513 stock on TipRanks’ Stock Analysis page.